HK1081203A1 - 9-Alpha-substituted estratrienes as selectively active estrogen - Google Patents

9-Alpha-substituted estratrienes as selectively active estrogen

Info

Publication number
HK1081203A1
HK1081203A1 HK06101276A HK06101276A HK1081203A1 HK 1081203 A1 HK1081203 A1 HK 1081203A1 HK 06101276 A HK06101276 A HK 06101276A HK 06101276 A HK06101276 A HK 06101276A HK 1081203 A1 HK1081203 A1 HK 1081203A1
Authority
HK
Hong Kong
Prior art keywords
alpha
selectively active
active estrogen
substituted estratrienes
estratrienes
Prior art date
Application number
HK06101276A
Other languages
English (en)
Inventor
Dirk Kosemund
Gerd Mueller
Alexander Hillisch
Karl-Heinrich Fritzemeier
Peter Muhn
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of HK1081203A1 publication Critical patent/HK1081203A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0055—Estrane derivatives not substituted in position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK06101276A 2002-06-11 2006-01-27 9-Alpha-substituted estratrienes as selectively active estrogen HK1081203A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10226326A DE10226326A1 (de) 2002-06-11 2002-06-11 9-alpha-substiuierte Estratriene als selektiv wirksame Estrogene
PCT/EP2003/006172 WO2003104253A2 (de) 2002-06-11 2003-06-11 9-alpha-substituierte estratriene als selektiv wirksame estrogene

Publications (1)

Publication Number Publication Date
HK1081203A1 true HK1081203A1 (en) 2006-05-12

Family

ID=29723144

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06101276A HK1081203A1 (en) 2002-06-11 2006-01-27 9-Alpha-substituted estratrienes as selectively active estrogen

Country Status (29)

Country Link
EP (1) EP1517914B1 (sr)
JP (1) JP4615998B2 (sr)
KR (1) KR101006612B1 (sr)
CN (1) CN1293090C (sr)
AR (1) AR040188A1 (sr)
AT (1) ATE303397T1 (sr)
AU (1) AU2003242683B9 (sr)
BR (1) BR0312140A (sr)
CA (1) CA2486495C (sr)
CR (1) CR10289A (sr)
CU (1) CU23414B7 (sr)
DE (2) DE10226326A1 (sr)
DK (1) DK1517914T3 (sr)
EA (1) EA008442B1 (sr)
EC (1) ECSP055530A (sr)
ES (1) ES2248770T3 (sr)
HK (1) HK1081203A1 (sr)
HR (1) HRP20050009B1 (sr)
IL (1) IL165321A (sr)
MX (1) MXPA04012491A (sr)
NO (1) NO329563B1 (sr)
PE (1) PE20040613A1 (sr)
PL (1) PL209910B1 (sr)
RS (1) RS50878B (sr)
TW (1) TWI286140B (sr)
UA (1) UA78062C2 (sr)
UY (1) UY27844A1 (sr)
WO (1) WO2003104253A2 (sr)
ZA (1) ZA200500217B (sr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
EP1689410B1 (en) * 2003-11-26 2008-05-21 Bayer Schering Pharma Aktiengesellschaft Prevention and treatment of hypertensive heart diseases by the selective estrogens 8beta-vinyl-estra-1,3,5(10)-trien-3,17beta-diol and 17beta-fluor-9alpha-vinyl-estra-1,3,5(10)-trien-3,16alpha-diol
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102005057224A1 (de) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
EP2252261A2 (en) * 2008-02-13 2010-11-24 Bayer Schering Pharma Aktiengesellschaft Drug delivery system with stabilising effect
EP2143432A1 (en) 2008-07-11 2010-01-13 Bayer Schering Pharma AG 9-alpha estratriene derivatives as ER-beta selective ligands for the prevention and treatment of intestinal cancer
CN102215818A (zh) * 2008-11-21 2011-10-12 拜耳先灵医药股份有限公司 药物递送系统
JP2017529388A (ja) 2014-08-26 2017-10-05 ベタニエン ホスピタル 炎症性病態の治療のための方法、薬剤および組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336432A1 (de) * 1973-07-13 1975-01-30 Schering Ag 3.17.18-trihydroxy-1.3.5(10)-oestratriene
US6154158A (en) * 1998-06-30 2000-11-28 Qualcomm Incorporated Digital-to-analog converter D.C. offset correction comparing converter input and output signals
DE19906159A1 (de) * 1999-02-09 2000-08-10 Schering Ag 16-Hydroxyestratriene als selektiv wirksame Estrogene
JP2003513102A (ja) * 1999-11-02 2003-04-08 シエーリング アクチエンゲゼルシャフト 選択的な作用を有するエストロゲンとしての１８−ノル−ステロイド
NZ543724A (en) * 2000-04-12 2007-07-27 Schering Ag 8beta-hydrocarbyl-substituted estratrienes as selectively active estrogens

Also Published As

Publication number Publication date
TW200407331A (en) 2004-05-16
NO20050127L (no) 2005-03-11
CN1659181A (zh) 2005-08-24
MXPA04012491A (es) 2005-06-08
BR0312140A (pt) 2005-04-05
WO2003104253A2 (de) 2003-12-18
JP4615998B2 (ja) 2011-01-19
CA2486495A1 (en) 2003-12-18
DK1517914T3 (da) 2006-01-16
HRP20050009A2 (en) 2005-04-30
AU2003242683B9 (en) 2009-08-27
DE50301116D1 (de) 2005-10-06
AR040188A1 (es) 2005-03-16
UA78062C2 (en) 2007-02-15
DE10226326A1 (de) 2004-01-15
NO329563B1 (no) 2010-11-15
RS50878B (sr) 2010-08-31
AU2003242683A1 (en) 2003-12-22
UY27844A1 (es) 2003-12-31
JP2005533053A (ja) 2005-11-04
RS107004A (en) 2006-10-27
IL165321A (en) 2009-08-03
NO20050127D0 (no) 2005-01-10
EP1517914B1 (de) 2005-08-31
ATE303397T1 (de) 2005-09-15
CA2486495C (en) 2011-04-19
KR20050009745A (ko) 2005-01-25
ES2248770T3 (es) 2006-03-16
AU2003242683B2 (en) 2009-07-02
EA008442B1 (ru) 2007-06-29
PL209910B1 (pl) 2011-11-30
HRP20050009B1 (hr) 2013-07-31
ECSP055530A (es) 2005-03-10
ZA200500217B (en) 2006-03-29
EP1517914A2 (de) 2005-03-30
KR101006612B1 (ko) 2011-01-10
CN1293090C (zh) 2007-01-03
PL373090A1 (en) 2005-08-08
WO2003104253A3 (de) 2004-09-16
TWI286140B (en) 2007-09-01
PE20040613A1 (es) 2004-12-01
CU23414B7 (es) 2009-09-08
CR10289A (es) 2008-11-26
EA200401544A1 (ru) 2005-06-30

Similar Documents

Publication Publication Date Title
ZA200602339B (en) HRT Formulations
IL175843A0 (en) Hrt formulations
AU2003266227A8 (en) Crossmember
ZA200507351B (en) Steroid spirolactonization
HK1081203A1 (en) 9-Alpha-substituted estratrienes as selectively active estrogen
PL370457A1 (en) New corticosteroids
GB2398992B (en) Underwear
SI1517914T1 (sl) 9-alfa-substituirani estratrieni kot selektivno ucinkoviti estrogeni
IL165321A0 (en) 9-alpha-substituted estratrienes as selectively active estrogen
IL173608A0 (en) 15-d-homosteroids having an androgenic effect
TW560398U (en) Improved structure for scissors
GB0411840D0 (en) An undergarment
AU154937S (en) An undergarment
GB2390533B (en) Undergarment
GB0203608D0 (en) Improved undergarment
GB0330045D0 (en) An envelope
ZA200609275B (en) D-homo-17-chloro-16(17)en steroids
ZA200602305B (en) Δ15-D-Homosteroids having an androgenic effect
CA94412S (en) Envelope
HU0200217V0 (en) Construction for newspaper
TW580978U (en) Improved structure for scissors
SI1539184T1 (sl) Rezim nadomestitve estrogena
AU153205S (en) Envelope
TW547388U (en) Improved structure for spoiler
IL181334A0 (en) 15??-substituted steroids having selective estrogenic activity

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140611